Comparative Analysis of Machine Learning Algorithms for Prognostic Prediction in Pulmonary Large Cell Carcinoma
Fan Yang1, Chaowen He1, Dongxuan Huang1
1Department of Respiratory Medicine, Shenzhen Longhua District Central Hospital, Shenzhen, China.
Cancer Control : Journal of the Moffitt Cancer Center
|April 27, 2026
Summary
Machine learning models, particularly Random Survival Forest, accurately predict overall survival for Large Cell Carcinoma (LCC) patients. This approach improves prognostic assessment and aids personalized treatment planning for this aggressive lung cancer subtype.
Area of Science:
- Oncology
- Data Science
- Bioinformatics
Background:
- Large Cell Carcinoma (LCC) is an aggressive non-small cell lung cancer with poor prognostic assessment.
- Conventional staging models inadequately capture LCC's biological complexity.
- Machine learning offers potential for improved prognostic accuracy and personalized treatment.
Purpose of the Study:
- To develop and validate machine learning models for predicting Overall Survival (OS) in LCC patients.
- To compare the performance of machine learning models against traditional methods.
- To identify key prognostic factors influencing OS in LCC.
Main Methods:
- Retrospective study using the SEER database (1,867 LCC patients).
- Feature selection using Lasso-Cox regression and Boruta algorithm.
- Model validation with time-dependent AUC, calibration plots, decision curve analysis, and Brier scores.
- Interpretability analysis using SHAP, PDP, and RCS.
Main Results:
- Random Survival Forest (RSF) outperformed Cox regression and other ML models.
- RSF achieved high AUC values for 3-year (0.858) and 5-year (0.863) OS prediction.
- Key prognostic factors identified: tumor size, metastatic status, and treatment interventions.
- Non-linear relationships between tumor size and survival were observed.
Conclusions:
- The developed machine learning framework, especially RSF, shows strong predictive performance for LCC patient OS.
- Identified prognostic factors provide insights into LCC behavior.
- A web-based platform enhances clinical utility for risk stratification and personalized treatment planning.
Related Concept Videos
Cancer Survival Analysis
860
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
860
Comparing the Survival Analysis of Two or More Groups
710
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
710

